Special Issue "A Deep Dive into the Ocean: Evaluation of Marine Compounds Bioactivity in the Omics Era"
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine Biotechnology Related to Drug Discovery or Production".
Deadline for manuscript submissions: 31 March 2024 | Viewed by 172
Special Issue Editors
Interests: proteomics; functional proteomics; mass spectrometry; bioorganic chemistry; marine bioactive compounds; small-molecules/proteins interactions
Interests: proteomics; functional proteomics; metabolomics; analytical chemistry; small-molecules/proteins interactions; marine-inspired compounds
Special Issues, Collections and Topics in MDPI journals
Interests: skin wound healing; angiogenesis; endothelial to mesenchymal and epithelial to mesenchymal transition; cancer biology; cell transfection; in vitro cultures; wound healing in mice; cell migration and invasion; pharmacology in general; extracellular vesicles isolation, characterization and use
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Comprising approximately half of the world's biodiversity, the marine environment represents a massive source of structurally multifaceted compounds, showing a range of complex and biologically relevant chemotypes. Indeed, marine products have been, and still are, a valuable source of drug discovery, being endowed with a wide spectrum of bioactivity. Despite the recent advances, a plethora of marine bioactive compounds still need to be explored to elucidate their mechanism of action. In this scenario, omics sciences represent a robust toolbox of complementary approaches, which clarify several aspects of bioactive molecule behavior, from its ability to influence certain cell transcriptomes, proteomes and/or metabolomes regarding their ability to specifically bind a set of proteins and thus exert their biological functions.
This Special Issue aims to showcase original research or review papers exploring marine bioactive compounds using omics strategies coupled with molecular biology and/or pharmacological approaches to obtain an in-depth characterization of their mechanisms of action.
Dr. Elva Morretta
Dr. Maria Chiara Monti
Dr. Raffaella Belvedere
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- functional proteomics
- proteins expression profiling
- proteins post-translational modifications analysis
- metabolomics
- transcriptomics
- multi-omics approaches
- biological activity
- pharmacological profiling.
